📚🧵📈Compilation of all threads we have written till now on Financial Analysis, Business Analysis, Valuations, Investing stalwart sessions @finnacleAcademy, Business leader stories, Summaries of investor memos/research papers and key takeaways of Investing webinars 👇🏻(1/8)

Financial Analysis: https://t.co/3PAxExuSsY (2/8)
Business Analysis: https://t.co/euKy8FTDDT (3/8)
Valuation Series: https://t.co/asuDmNGDEB (4/8)
Investing Stalwart sessions @FinnacleAcademy : https://t.co/09x4ozDGvg (5/8)
Summaries of investor memos/research papers: https://t.co/4dIKZu8V5I (6/8)
Key takeaways of Investing webinars: https://t.co/nSapiStYK5 (7/8)
Business Leader Stories: https://t.co/SWFQTDyHz3 (8/8)
Watch our YouTube videos on Financial analysis, Business analysis and Valuation here:
https://t.co/xbNXnVypZp

To continue your learning and fun with finance follow us on Instagram: https://t.co/0mv9MU234g

You May Also Like

@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)

@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice


@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2


@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj


@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o